Showing results (121-130 of 330) with videos related to

Sort By:
Pageof 33
Journal of Diabetes|March 6, 2012
Maternal antioxidants prevent β-cell apoptosis and promote formation of dual hormone-expressing endocrine cells in male offspring following fetal and neonatal nicotine exposureJennifer E Bruin, Amanda K Woynillowicz, Bart P Hettinga, et al.
Cerebral Circulation - Cognition and Behavior|May 27, 2024
Visit-to-visit variability in multiple biological measurements and cognitive performance and risk of cardiovascular disease: A cohort studyLaura Sherlock, Shun Fu Lee, Tali Cukierman-Yaffe, et al.
Journal of Diabetes and Its Complications|April 28, 2021
NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia - A brief report from the ORIGIN trialMagnus O Wijkman, Brian L Claggett, Marc A Pfeffer, et al.
Lancet (London, England)|July 8, 2010
Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled studyBernard Zinman, Stewart B Harris, Jan Neuman, et al.
Scientific Reports|September 22, 2017
Optimizing the methodology for measuring supraclavicular skin temperature using infrared thermography; implications for measuring brown adipose tissue activity in humansTahniyah Haq, Justin D Crane, Sarah Kanji, et al.
Archives of Internal Medicine|August 13, 2008
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) programHertzel C Gerstein, Karl Swedberg, Jonas Carlsson, et al.
Canadian Journal of Diabetes|February 4, 2022
Economic Analysis of a Diabetes Health Coaching Intervention for Adults Living With Type 2 Diabetes: A Single-Centre Evaluation From a Community-Based Randomized Controlled TrialDaria J O'Reilly, Gord Blackhouse, James M Bowen, et al.
Diabetes Research and Clinical Practice|January 23, 2009
Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programmeTali Cukierman-Yaffe, Hertzel C Gerstein, Craig Anderson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 29, 2003
Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized studyJohannes F E Mann, Hertzel C Gerstein, Qi-Long Yi, et al.
Diabetes, Obesity & Metabolism|June 7, 2022
Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin to iGlarLixi in the LixiLan ONE CAN randomized trialIrene Hramiak, Hertzel C Gerstein, Lawrence A Leiter, et al.
Pageof 33